Targeting TWEAK/Fn14 pathway: Implications for stem cell regulation and advancements in skin disease therapies

Ahmad Taha Khalaf1, Xiaoming Liu2

  • 1Medical College, Anhui University of Science and Technology (AUST), Huainan 232001, China.

PubMed

Insights

Tumor necrosis factor-like weak apoptosis-inducing factor (TWEAK) and its receptor Fn14 are crucial in cell regulation and disease. This pathway

Area of Science:

  • Immunology
  • Cell Biology
  • Dermatology

Background:

  • Tumor necrosis factor-like weak apoptosis-inducing factor (TWEAK) is a TNF superfamily member that signals through fibroblast growth factor-inducible 14 (Fn14).
  • This TWEAK/Fn14 pathway regulates critical cellular functions like proliferation, differentiation, and migration.
  • Dysregulation of TWEAK/Fn14 signaling is implicated in various diseases, including skin disorders and stem cell behavior.

Purpose of the Study:

  • To review the dual roles of TWEAK/Fn14 signaling in skin disease pathogenesis.
  • To examine the influence of TWEAK/Fn14 signaling on stem cell regulation.
  • To highlight the potential of TWEAK/Fn14 as a diagnostic biomarker and therapeutic target.

Main Methods:

  • Literature review of studies on TWEAK/Fn14 signaling.
  • Analysis of TWEAK/Fn14 involvement in skin disorders (e.g., lupus, psoriasis).
  • Investigation of TWEAK/Fn14 effects on stem cell behavior (liver, neural, mesenchymal).

Main Results:

  • TWEAK/Fn14 signaling is upregulated in skin diseases, contributing to fibroproliferation, angiogenesis, and inflammation.
  • Moderate TWEAK/Fn14 activation aids wound healing, while excessive activation causes pathological damage.
  • TWEAK/Fn14 influences stem cell proliferation and differentiation, impacting tissue repair and regeneration.

Conclusions:

  • The TWEAK/Fn14 pathway exhibits a dual role, promoting healing at moderate levels but causing damage when overactivated.
  • TWEAK/Fn14 signaling is a key factor in skin disease development and stem cell modulation.
  • Targeting the TWEAK/Fn14 pathway offers potential for early disease detection and novel therapeutic strategies in regenerative medicine and tissue engineering.

Related Concept Videos

Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
3.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.3K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Stem Cell Niche01:26

Stem Cell Niche

The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.2K
Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.1K